El mercado de servicios de investigación de resultados y economía de la salud (HEOR) se valoró en 1.116,38 millones de dólares en 2019 y se prevé que alcance los 2.699,56 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 11,9 % entre 2020 y 2027.
Los servicios de investigación de resultados y economía de la salud (HEOR) desempeñan un papel importante en la aprobación y el reembolso de medicamentos con los pagadores. Los servicios HEOR permiten evaluar la economía del tratamiento y cuantificar los resultados asociados. Del mismo modo, en la industria de la salud, los tomadores de decisiones experimentan la presión de optar por "intervenciones" terapéuticas. de diversas opciones de tratamiento ofrecidas por empresas farmacéuticas, de dispositivos médicos y de biotecnología. El crecimiento del mercado general de servicios de investigación de resultados y economía de la atención médica (HEOR) se atribuye al creciente desarrollo de productos y al creciente gasto en atención médica. Sin embargo, las restricciones al acceso a datos del mundo real (RWD) son el principal factor que obstaculiza el crecimiento del mercado.
Se espera que el mercado de servicios de investigación de resultados y economía de la atención sanitaria (HEOR) experimente un crecimiento sustancial después de la pandemia. La infraestructura sanitaria mundial observó limitaciones y capacidades durante la repentina aparición del coronavirus. Para hacer frente a este tipo de situaciones en los próximos años, se espera que las organizaciones sanitarias y los gobiernos aumenten la utilización de los servicios HEOR, lo que eventualmente impulsará el crecimiento del mercado. Además, también se prevé que la demanda de tecnologías avanzadas de análisis de datos impulse el crecimiento del mercado.
Mercado de servicios de investigación de resultados y economía de la salud (HEOR)
Perspectivas del mercado
Aumento del gasto en atención sanitaria para impulsar el crecimiento del mercado de servicios de investigación de resultados y economía de la salud (HEOR)
Aumento de la renta disponible, aumento de la concienciación En lo que respecta a productos y servicios técnicamente avanzados, el aumento de la demanda de excelentes servicios sanitarios y de políticas de reembolso y seguros sanitarios están provocando un aumento del gasto sanitario en todo el mundo. Según el informe de la Organización Mundial de la Salud (OMS), "Gasto público en salud: una mirada más cercana a las tendencias globales", Según datos publicados en 2016, se gastaron ~7,5 billones de dólares en salud. Es casi el 10% del producto interno bruto (PIB) mundial. De manera similar, según el informe actualizado de la OMS para 2018, "Gasto público en salud: una mirada más cercana a las tendencias globales", El gasto total en atención sanitaria está creciendo más rápido que el PIB. Está aumentando más rápidamente en los países de ingresos bajos y medios, con un promedio de casi el 6 % en comparación con los países de ingresos altos, que es ~4 %.
Sin embargo, este gasto se puede ahorrar si se gestiona adecuadamente el dinero para evitar más gastos en los 'dominios de desperdicio', como la falta de atención, la coordinación inadecuada, el tratamiento excesivo o la atención de bajo valor, la falla en los precios, el fraude y el abuso, y varias complejidades administrativas. La Organización para la Cooperación y el Desarrollo Económico (OCDE) está tratando de determinar el desperdicio mínimo del gasto en atención médica. Según un informe de la OCDE de 2017, "una proporción significativa del gasto en salud en los países de la OCDE es, en el mejor de los casos, ineficaz y, en el peor, un desperdicio". Una quinta parte del gasto total en salud puede canalizarse adecuadamente para un uso eficiente. Más del 9% del PIB se gasta en los países de la OCDE, de los cuales tres cuartas partes son pagadas por los gobiernos. Este despilfarro debilita la sostenibilidad financiera de los sistemas de salud. Por lo tanto, la sostenibilidad financiera requiere una gestión adecuada, y el dinero puede utilizarse mediante un diagnóstico y una planificación de tratamiento adecuados para reducir el coste de los servicios sanitarios.
En tales casos, el HEOR desempeña un papel vital al proporcionar evidencia comparativa para elección de productos y servicios. Seleccionar el producto o servicio adecuado ayudaría a mejorar los resultados de salud de los pacientes con un gasto sanitario justificado. Proporciona los conocimientos más valiosos que conducen a una reducción del desperdicio de productos, servicios y dinero. Esta evidencia es esencial para identificar las mejores políticas de implementación de presupuestos de atención médica que beneficiarían a los pacientes. Los servicios HEOR también ayudarían a los proveedores de servicios sanitarios a prestar atención a gastos inciertos en cirugías y procedimientos clínicos innecesarios. Es probable que la consulta de HEOR fomente el uso de medicamentos genéricos, aumente el enfoque en la actualización de las habilidades de enfermería de las enfermeras para manejar las condiciones crónicas de los pacientes y garantice que no haya estadías hospitalarias para los pacientes que no requieren atención hospitalaria y pueden ser tratados con menos recursos. atención primaria. Por lo tanto, es probable que el creciente gasto en atención médica influya en el crecimiento del mercado de servicios HEOR durante el período de pronóstico.
Información basada en servicios
En términos de servicio, la economía de la atención médica y la investigación de resultados (HEOR ) el mercado de servicios se segmenta en modelado/evaluación económica, análisis de datos del mundo real y sistemas de información, resultados clínicos y soluciones de acceso al mercado y reembolso. El segmento de resultados clínicos tuvo la mayor participación de mercado en 2019, y se estima que el segmento de sistemas de información y análisis de datos del mundo real registrará la CAGR más alta durante el período de pronóstico.
Mercado de servicios de investigación de resultados y economía de la salud (HEOR), por servicio: 2019 y 2027
Perspectivas basadas en proveedores de servicios
Basado en el proveedor de servicios, la economía de la salud y la investigación de resultados ( HEOR) el mercado de servicios se segmenta en consultoría y organización de investigación por contrato. En 2019, el segmento de organizaciones de investigación por contrato tuvo una mayor participación de mercado; además, se estima que el mismo segmento registrará una CAGR más alta durante 2020-2027.
Usuario final- Insights basados
El mercado de servicios de investigación de resultados y economía de la salud (HEOR), por proveedor de servicios, se segmenta en consultoría y organización de investigación por contrato. En 2019, el segmento de organizaciones de investigación por contrato tuvo la mayor participación del mercado; además, se estima que el mismo segmento registrará una CAGR más alta durante 2020-2027.
Perspectivas estratégicas< /h3>
Los actores del mercado de investigación de resultados y economía de la salud (HEOR) están adoptando estrategias de expansión y lanzamiento de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
Mercado de servicios de investigación de resultados y economía de la salud (HEOR): por servicio
- Evaluación/modelado económico
- Análisis de datos y sistemas de información del mundo real
- Resultados clínicos
- Soluciones de acceso al mercado y reembolso
Mercado de servicios de investigación de resultados y economía de la salud (HEOR): por proveedor de servicios
- Consultoría
- Organizaciones de investigación por contrato
Mercado de servicios de investigación de resultados y economía de la salud (HEOR): por usuario final
- Proveedores de atención médica
- Pagadores de atención médica
- Empresas biotecnológicas/farmacéuticas
- Organizaciones gubernamentales
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- Suramérica y Centroamérica (SCAM)
- Brasil
- Argentina
- Resto de SCAM
< /ul> - Axtria, Inc.
- Avalon Health Economics LLC
- MEDLIOR
- PHARMALEX GMBH
- Grupo de análisis
- ICON PLC
- IQVIA Inc.
- McKESSON CORPORATION
- Syneos Health
- Optum, Inc.
Mercado de servicios de investigación de resultados y economía de la salud (HEOR): por Geografía
Perfiles de la empresa
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Health economics and outcomes research (HEOR) services play a significant role in drug approval and reimbursement with payers. The HEOR services allow to evaluate the economics of treatment and quantify the associated results. Likewise, in the healthcare industry, decision-makers experience the pressure to opt for therapeutic ‘interventions’ from various treatment options made available by pharmaceuticals, medical devices, and biotechnology companies. Also, there is constant pressure to control the rising healthcare cost. Therefore, HEOR services help decision-makers to adequately compare and understand the appropriate option among all the available options.
The growth of the overall healthcare economics and outcomes research (HEOR) services market is attributed to the increasing product development and growing healthcare spending.
The health economics and outcomes research (HEOR) services market majorly consists of the players such as Axtria, Inc., Avalon Health Economics LLC, MEDLIOR, PHARMALEX GMBH, Analysis Group, ICON PLC, IQVIA Inc., McKESSON CORPORATION, Syneos Health, and Optum, Inc. amongst others.
The List of Companies - Health Economics and Outcomes Research (HEOR) Services Market
- Axtria, Inc.
- Avalon Health Economics LLC
- MEDLIOR
- PHARMALEX GMBH
- Analysis Group
- ICON PLC
- IQVIA Inc.
- McKESSON CORPORATION
- Syneos Health
- Optum, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Emergency Call Systems Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Fall Prevention and Detection, Workflow Optimization, Patient Care Reminders, Alarms and Communication Management, Wander Management, Reporting and Analytics, Real-Time Staff Locating, and Others), End User (Hospital and Clinics, Assisted Living and Independent Living Facilities, Ambulatory Surgical Centers, and Others), Technology (Wired and Wireless), Offering (Hardware, Software, and Services), Product Type (Nurse Call Systems, Call Box Systems, Emergency Stanchions, Intercom System, and Others),, and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
Outpatient Central Fulfillment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Well-Being Platform Market
Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
Feb 2021
Product Design and Development Services Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Services (Research, Strategy, and Concept Generation; Concept and Requirement Development; Detailed Design and Process Development; Process Validation, Manufacturing Transfer, and Design Validation; and Other Services), Application (Diagnostic Equipment, Therapeutic Equipment, Surgical Instruments, Clinical Laboratory Equipment, Biological Storage, Consumables, and Others), and End User (Medical Companies, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations)
Feb 2021
Patient Engagement Technology Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Services, Hardware, and Software), Therapeutic Area (Fitness, Chronic Diseases, Women’s Health, and others), Delivery Mode (Cloud-Based and On-Premises), Application (Health Management, Financial Health Management, Home Healthcare Management, and Others), and End User (Patients, Payers, Providers, and Others)
Feb 2021
IVD Contract Research Organization Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
Feb 2021
Dental CAD/CAM Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Dental CAD/CAM Materials (Glass Ceramics, Alumina-Based Ceramics, Lithium Disilicate, Zirconia, and Others) and Dental CAD/CAM Systems], Type (In-Office Systems and In-Lab Systems), Components [Hardware (Dental Printers, Milling Machines, Scanners, and Others) and Software], Application (Dental Prosthesis, Dental Implants, and Others), and End User (Dental Clinics, Dental Laboratories, Milling Centers, and Others)
Feb 2021
Emergency Medical Software Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Early Warning and Vulnerability Alert System (EWVAS), EMS Computer Aided Dispatch (CAD) System, Incident Response Software, Ambulance Management Software, and Others], Mode of Delivery [On Premises and Software as a Service (SaaS)], Platform (Android, iOS, Windows, and Others), and End User (Commercial, Municipal, State City Agencies, and Others)